The Clinical Impact of Early Steroid Withdrawal on Diabetes Mellitus After Liver Transplantation: A Population-Based Cohort Study
Transplant International · 2026
DOI: 10.3389/ti.2026.15432 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Transplant International, 2026. Verfasst von Haeseon Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. Hauptthemen laut MEDLINE: Liver Transplantation, Diabetes Mellitus, Adrenal Cortex Hormones. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Despite the metabolic risks associated with corticosteroids after liver transplantation (LT), the optimal timing for their withdrawal remains uncertain due to limited and inconsistent evidence. To evaluate the impact of corticosteroid withdrawal timing on the development of de-novo post-transplant diabetes mellitus (PTDM), we performed a retrospective cohort study of 6,295 adult recipients who underwent LT between 2009 and 2021 in South Korea, utilizing a national health insurance claims database. A landmark analysis with time-varying propensity score matching was conducted at one-, three-, and six-month post-transplantation to compare the incidence of PTDM between steroid withdrawal and maintenance groups. Early steroid withdrawal within 3 months significantly reduced PTDM risk (HR = 0.586; 95% CI = 0.407–0.846 at 1 month, HR = 0.766; 95% CI = 0.611–0.960 at 3 month), whereas withdrawal after 3 months showed no significant benefit (HR = 0.844; 95% CI = 0.619–1.152 at 6 month). Rejection events were rare, suggesting no substantial compromise in graft function. These findings indicate that corticosteroid withdrawal within the first three months post-LT can lower the risk of PTDM without increasing rejection risk, supporting timely steroid tapering as part of post-transplant immunosuppressive strategies to reduce long-term metabolic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, United States.
- Institute of Regulatory Innovation Through Science (IRIS), Kyung Hee University, Seoul, Republic of Korea.
- Seoul National University Hospital, College of Medicine, Seoul National University, Seoul, Republic of Korea.
- College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
Zitieren
APA
Lee, H., Choi, Y., & Suh, H. S. (2026). The Clinical Impact of Early Steroid Withdrawal on Diabetes Mellitus After Liver Transplantation: A Population-Based Cohort Study. Transplant International. https://doi.org/10.3389/ti.2026.15432
Vancouver
Lee H, Choi Y, Suh HS. The Clinical Impact of Early Steroid Withdrawal on Diabetes Mellitus After Liver Transplantation: A Population-Based Cohort Study. Transplant International. 2026. doi:10.3389/ti.2026.15432
BibTeX
@article{Lee2026,
author = {Lee, Haeseon and Choi, YoungRok and Suh, Hae Sun},
title = {The Clinical Impact of Early Steroid Withdrawal on Diabetes Mellitus After Liver Transplantation: A Population-Based Cohort Study},
journal = {Transplant International},
year = {2026},
doi = {10.3389/ti.2026.15432}
}
EUVIMED